Vita Intelligence

Known for

Vivy: GLP1 & GLP 1 Tracker

1app

Active nemesis

Shotsy

Other rivals

Publisher DNA

AI intelligence is not yet available for Vita Intelligence. The portfolio data below is up to date.

Top niches they play in

Diabetes Management Trackers1 app

Explore the Diabetes Management Trackers niche

See every app competing in Vita Intelligence's strongest niche.

Go deeper

Portfolio

Apps

1 app analysed

Sort by

Vivy: GLP1 & GLP 1 Tracker

4.8(653)

View Intel →

GLP-1 specific community fosters peer-to-peer retention

Doctor-developed positioning builds clinical trust
Subscription-only model for core features limits top-of-funnel conversion

Tightly focused on 2 markets (Mexico, United States).

Based on 1 of 1 app with localized market data · last scanned May 2026.

Americas (2)

User sentiment

Positive apps

Neutral / mixed

Negative apps

85/100

Avg sentiment score

Top performer

Vivy: GLP1 & GLP 1 Tracker

Excited sentiment

Rivals

The rivals identified

Nemeses(1)

Shotsy

known forShotsy GLP-1 Tracker

1 app

So what?

Strategic outlook coming soon.

Frequently asked questions

How many apps does Vita Intelligence publish?

Vita Intelligence has 1 app tracked by Marlvel, primarily in the Health & Fitness category.

What kind of apps does Vita Intelligence make?

Vita Intelligence's portfolio is concentrated in Health & Fitness, with an average rating of 4.8/5 across rated apps.

app

Health & Fitness1

Last updated

Vivy: GLP1 & GLP 1 Tracker

v3.4.4

3mo ago

Core markets (1/1 apps)

MexicoUnited States

Shotsy is the direct market leader in the GLP-1 niche, competing for the same user base seeking specialized medication tracking and dosage visualization.

Contenders(4)

Marcin Jedrzejak

known forMedisafe Carezone: PillMemo

1 app4.9Health & Fitness

View Intel →

PillMemo competes on the basis of simple, unlimited medication tracking and inventory management for patients with complex regimens.

MedM

known forBlood Sugar Diary for Diabetes

1 app4.5Health & Fitness

View Intel →

Shred Apps

known forGLP-1 Tracker: Pep

1 app4.6Health & Fitness

View Intel →

smartpatient

known forPill Reminder MyTherapy

1 appHealth & Fitness

View Intel →

MyTherapy is a mature, high-trust medical app that competes for users who prioritize medication adherence and clinical reporting.

Same space(4)

Colsubsidio

known forMedicamentos Colsubsidio

1 app2.8Health & Fitness

View Intel →

This app competes in the broader medication management ecosystem by facilitating pharmacy logistics and appointment booking.

Dexcom

known forStelo by Dexcom

1 app2.9Health & Fitness

View Intel →

Gluroo Imaginations

known forGluroo CGM Watchface

1 app3.9Health & Fitness

View Intel →

Marwan Elwaraki

known forSweet Dreams – Sugar Tracker

1 app4.7Health & Fitness

View Intel →

New entrants(2)

Dropouts Technologies LLP

known forEasy GLP 1 Tracker

1 app0.0Health & Fitness

View Intel →

A new entrant focusing on Apple Intelligence and clinical reporting to capture users looking for modern, automated insights.

Ramkumar Vellaisamy

known forPill Reminder: Med-Alarm

1 app0.0Health & Fitness

View Intel →

What is Vita Intelligence's top app?

Based on user sentiment and following across the portfolio, Vivy: GLP1 & GLP 1 Tracker stands out as Vita Intelligence's flagship app tracked by Marlvel.

In how many countries are Vita Intelligence's apps available?

Marlvel has tracked Vita Intelligence's apps across 2 countries.

This app targets the medical-grade tracking segment, appealing to users who require Bluetooth connectivity and multi-parameter health logging.

Pep competes by offering a broader lifestyle-focused feature set, including AI-driven food scanning and injection site rotation.

Stelo competes by providing hardware-backed biosensor data, which is the gold standard for metabolic health monitoring.

Gluroo targets the power-user segment that requires real-time synchronization between CGM data and insulin pump management.

This app overlaps by focusing on the metabolic health and blood sugar tracking aspects often associated with GLP-1 usage.

This newcomer enters the space with a privacy-first approach to medication reminders and history tracking.

Snapshot

Publisher DNA

Top niches they play in

Portfolio

Apps

Americas (2)

User sentiment

Rivals

The rivals identified

Nemeses(1)

So what?

Frequently asked questions

Core markets (1/1 apps)

Contenders(4)

Same space(4)

New entrants(2)